Cardiovascular disease and cancer share many parallels in their origins and how they develop. Nanoparticles offer one potential way to effectively treat both with reduced side effects.
Could a single drug treat the two leading causes of death in the US: cancer and cardiovascular disease?
Bryan Smith, Associate Professor of Biomedical Engineering, Michigan State University